rs10493148
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_014278.4(HSPA4L):c.2167-192T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0303 in 152,294 control chromosomes in the GnomAD database, including 298 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.030 ( 298 hom., cov: 32)
Consequence
HSPA4L
NM_014278.4 intron
NM_014278.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.57
Publications
3 publications found
Genes affected
HSPA4L (HGNC:17041): (heat shock protein family A (Hsp70) member 4 like) The protein encoded by this gene is heat shock inducible and may act as a chaperone. The encoded protein can protect the heat-shocked cell against the harmful effects of aggregated proteins. This gene is highly expressed in leukemia cells and may be a good target for therapeutic intervention. Several transcripts encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.251 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HSPA4L | NM_014278.4 | c.2167-192T>C | intron_variant | Intron 17 of 18 | ENST00000296464.9 | NP_055093.2 | ||
| HSPA4L | NM_001317381.2 | c.2260-192T>C | intron_variant | Intron 18 of 19 | NP_001304310.1 | |||
| HSPA4L | NM_001317382.2 | c.2089-192T>C | intron_variant | Intron 17 of 18 | NP_001304311.1 | |||
| HSPA4L | NM_001317383.2 | c.2044-192T>C | intron_variant | Intron 16 of 17 | NP_001304312.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0303 AC: 4617AN: 152176Hom.: 299 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4617
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0303 AC: 4612AN: 152294Hom.: 298 Cov.: 32 AF XY: 0.0346 AC XY: 2574AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
4612
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
2574
AN XY:
74448
show subpopulations
African (AFR)
AF:
AC:
152
AN:
41578
American (AMR)
AF:
AC:
1346
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
24
AN:
3468
East Asian (EAS)
AF:
AC:
1358
AN:
5174
South Asian (SAS)
AF:
AC:
85
AN:
4824
European-Finnish (FIN)
AF:
AC:
642
AN:
10610
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
945
AN:
68038
Other (OTH)
AF:
AC:
60
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
201
401
602
802
1003
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
440
AN:
3472
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.